SCHEMBL28899951

SCHEMBL28899951

COC(=O)c1[nH]c(=O)c2cc(Oc3cccs3)ccc2c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
GAA P10253 4/20 0.56
HTT P42858 3/20 0.56
KDM4E B2RXH2 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
PADI4 Q9UM07 1/20 0.56
HPGD P15428 3/20 0.42
ERCC1 P07992 1/20 0.40
FEN1 P39748 1/20 0.40
ERCC4 Q92889 1/20 0.40
PARP15 Q460N3 3/20 0.39
PARP10 Q53GL7 3/20 0.39
TNKS2 Q9H2K2 3/20 0.39
PARP2 Q9UGN5 2/20 0.39
PARP14 Q460N5 1/20 0.39
SERPINE1 P05121 1/20 0.39
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29922978 1.00 ALDH1A1 (0.56) ALDH1A1GAAHTTKDM4ENPSR1
SCHEMBL14672079 0.82 ALDH1A1 (0.67) ALDH1A1GAAHTTKDM4ENPSR1
SCHEMBL22451332 0.81 KDM4E (0.67) ALDH1A1GAAHTTKDM4ENPSR1
SCHEMBL28899887 0.76 THRB (0.50) GAAHTTERCC1FEN1ERCC4
SCHEMBL28899808 0.75 THRA (0.50) ERCC1FEN1ERCC4
SCHEMBL29923141 0.75 THRA (0.50) ERCC1FEN1ERCC4
SCHEMBL3583941 0.74 ALDH1A1 (0.68) ALDH1A1GAAHTTKDM4ENPSR1
SCHEMBL3580260 0.73 ALDH1A1 (1.00) ALDH1A1GAAHTTKDM4ENPSR1
SCHEMBL13440423 0.73 ALDH1A1 (0.67) ALDH1A1GAAHTTKDM4ENPSR1
SCHEMBL22441918 0.70 ALDH1A1 (0.69) ALDH1A1GAAHTTKDM4ENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107382986-B 4-hydroxy-1-methylisoquinoline derivatives and their use in increasing endogenous erythropoietin 江苏艾立康医药科技有限公司 2022-09-20 CN disclosed